ST. LOUIS & NEW YORK–(BUSINESS WIRE)–Perficient launches Agentic Front Office, an AI-powered solution that helps organizations accelerate execution across the sales lifecycle.
Month: September 2026
CANTON, Mass.–(BUSINESS WIRE)– #Expanse–MEDITECH has completed implementation of its Expanse EHR platform across 34 hospitals in HCA Healthcare’s Capital and North Florida divisions.
OVERLAND PARK, Kan.–(BUSINESS WIRE)–Archer® today launched Archer Evolv™ Foundation and Archer Evolv™ Workplace, putting a governed digital workforce to work inside the GRC system of record enterprises already trust. Archer Evolv Foundation is the shared AI intelligence layer beneath that workforce, holding every Operator inside the controls and permissions already in place. Archer Evolv Workplace is the marketplace through which customers select governed AI Operators and assign them to their
LONDON–(BUSINESS WIRE)– Re: ATLAS FUNDING 2023 -1 PLC GBP 2,289,000.00 MATURING: 20-Jan-2061 ISIN: XS2601815645 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 11.24 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 8,438.21 PER GBP 856,584.61 DENOMINATION
غنت، بلجيكا وطوكيو–(BUSINESS WIRE)–أعلنت .H.U. Group Holdings Inc وشركتها التابعة المملوكة بالكامل Fujirebio اليوم أن وكالة تنظيم الصحة البرازيلية (ANVISA) قد منحت تصريحًا للسوق لفحوصات Lumipulse G NfL Blood وLumipulse G pTau 217 Plasma للاستخدام على منصة المقايسة المناعية LUMIPULSE® G المؤتمتة بالكامل في البرازيل.قال Christiaan De Wilde، الرئيس التنفيذي لشركة .Fujirebio Europe N.V: “إن ترخيص ANVISA لاختباري Lumipulse G NfL Blood وLumipulse G pTau 217 Plasma يمثل خطوة مهمة أخرى في مهمتنا لتوسي
LONDON–(BUSINESS WIRE)– Re: ATLAS FUNDING 2023 -1 PLC GBP 10,132,000.00 MATURING: 20-Jan-2061 ISIN: XS2601488773 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 6.49 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 60,653.48 PER GBP 10,666,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: Atlas Funding 2025-2 plc GBP 3,600,000.00 MATURING: 20-Jul-2067 ISIN: XS3212017506 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 6.71 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 15,371.14 PER GBP 2,614,363.27 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: ATLAS FUNDING 2023 -1 PLC GBP 18,818,000.00 MATURING: 20-Jan-2061 ISIN: XS2601487023 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 5.64 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 97,884.46 PER GBP 19,809,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: Atlas Funding 2026-1 PLC GBP 432,170,000.00 MATURING: 20-Jan-2068 ISIN: XS3346958914 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 4.56 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 1,679,689.62 PER GBP 420,492,891.73 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: ATLAS FUNDING 2023 -1 PLC GBP 4,342,000.00 MATURING: 20-Jan-2061 ISIN: XS2601696458 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Aug-2026 TO 21-Sep-2026 HAS BEEN FIXED AT 9.49 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Sep-2026 WILL AMOUNT TO: GBP 38,015.89 PER GBP 4,571,000.00 DENOMINATION